Analytical Data
-
Gene name
FLAD1
- Application
-
Alternative Names
FAD pyrophosphorylaseFMN adenylyltransferaseFlavin adenine dinucleotide synthase 2 domains:Molybdenum cofactor biosynthesis protein-like regionFAD synthase region
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NFF5
-
Expression Region
1-490aa
-
Molecular Weight
58.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLAD1, or FlaB-like activator domain 1, is a protein implicated in various cellular processes, including gene regulation and post-transcriptional modifications. Its role in cellular mechanisms has drawn significant interest in the fields of molecular biology and biochemistry, particularly due to its potential involvement in disease pathways, such as cancer and metabolic disorders. Research indicates that FLAD1 may influence the stability and abundance of specific RNA molecules, thus affecting gene expression profiles crucial for cell growth and differentiation. The construction of recombinant FLAD1 proteins enables researchers to investigate its functional properties and interactions in vitro and in vivo. Studies utilizing FLAD1 recombinant proteins can elucidate the molecular mechanisms underlying its regulatory functions, potentially revealing novel therapeutic targets. Furthermore, understanding the structural characteristics of FLAD1 through recombinant protein studies may enhance our knowledge of protein-protein and protein-RNA interactions essential for maintaining cellular homeostasis. Thus, the research on FLAD1 recombinant proteins not only contributes to the fundamental understanding of gene expression regulation but also holds promise for identifying new intervention strategies for various diseases linked to aberrant FLAD1 activity.
